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Introduction
A novel elastin-binding, Gadolinium-based low molecu-
lar weight contrast agent, BMS753951 (Bristol Myers
Squibb, Billerica, MA) may be useful for visualization of
the artery wall by delayed-enhancement magnetic reso-
nance imaging (MRI). Synthesis and degradation of the
extracellular matrix (ECM), including elastin, plays a cen-
tral role in the natural progression of atherosclerosis. In
particular, excessive ECM degradation in the advanced
plaques has been suggested to be associated with plaque
instability.
Purpose
Because elastin is involved in remodeling of the ECM in
the atherosclerotic artery wall, we sought to study uptake
patterns of BMS753951 in the thoracic and abdominal
aorta of atherosclerotic mice by delayed-enhancement MR
imaging.
Methods
Mice ageing 6 months lacking both apolipoprotein E and
the cytoplasmic domain of tissue factor (ApoE-/- TFΔct)
were fed on hypercholesteraemic diet for 3 months. Then
MRI from the aortic bifurcation to the level of diaphragm
was performed using a 1.5-T clinical scanner (Achieva,
Philips Medical Systems, NL) equipped with a small sin-
gle loop animal coil (∅ = 47 mm). Course of the aortic
lumen was displayed for the assessment of atherosclerotic
narrowings and planning of the vessel wall scan on 3D
time-of-flight (TOF) fast gradient echo angiography (field
of view 30 mm, matrix 100 × 100, in-plane resolution 0.3
mm, slice thickness 1 mm, 32 slices, TR/TE 26/5 ms, flip
angle 60 degrees) and coronal maximum intensity projec-
tions. Forty five minutes after injection of 0.2 mmol/kg of
BMS75395, delayed-enhancement imaging using a 3D
gradient echo inversion recovery sequence (field of view
35 mm, matrix 292 × 292, in-plane resolution 0.12 mm,
slice thickness 1 mm, 32 slices, TR/TE 37/10 ms, and flip
angle 40 degrees) was performed to detect contrast uptake
within the aortic vessel wall. The inversion time was
adjusted to null blood by simulating plasma concentra-
tion of Gadolinium as a function of time (typically ≈ 300
ms). After the imaging experiment, animals were eutha-
nized and aortas were collected for immunohistochemis-
try and examination of the elastin content. The extent of
atherosclerotic lesions was analyzed by Sudan IV staining.
Results
Time-of-flight angiography showed significant luminal
narrowing in the subrenal aorta when compared with the
suprarenal aorta in all atherosclerotic mice. On average,
the maximal luminal narrowing was 55 ± 4.7%. Contrast
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uptake after injection of BMS753951 correlated well with
sites of luminal narrowing and showed some slice-to-slice
and intraplaque heterogeneity (Figure 1). Delayed
enhancement was strongest at the luminal side of the
investigated plaques. In the areas showing highest
enhancement average contrast-to-noise ratio (CNR)
between the vessel wall and aortic blood was 22.2 ± 5.5.
Per cross section, average CNR between the vessel wall
and aortic blood at the site of luminal narrowing was 3.1
times higher than in the suprarenal, non-stenosed aorta
(9.4 ± 1.4 vs. 3.0 ± 1.0; p < 0.01, Figure 2).
Conclusion
Delayed-enhancement MRI demonstrates focal uptake of
a novel gadolinium-based elastin-binding contrast agent
in the atherosclerotic abdominal aorta of ApoE-/- TFΔct
mice with little uptake in the non-stenotic suprarenal ves-
sel segements. In addition, contrast uptake appeared to
co-localize with the fibrous cap and thus may be poten-
tially useful for the detection of unstable plaques.
Figure 2
Delayed-enhancement MRI demonstrated focal uptake of a novel gadolinium-based elastin-binding contrast agent in the atheroscl rotic abdominal aorta of ApoE-/- TFct mice witli tl  uptake in the non-sten tic suprarenal ve sel seg mentsFigur  1
Delayed-enhancement MRI demonstrated focal uptake of a 
novel gadolinium-based elastin-binding contrast agent in the 
atherosclerotic abdominal aorta of ApoE-/- TFct mice with 
little uptake in the non-stenotic suprarenal vessel segements.Page 2 of 2
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